Works matching AU Schneider, Bruce S.

Results: 4

Summary of the 2000 Surgeon General's Listening Session: Toward a National Action Plan on Overweight and Obesity.
Published in:
Obesity (19307381), 2002, v. 10, n. 12, p. 1299, doi. 10.1038/oby.2002.176
By:
- Jackson, Yvonne;
- Dietz, William H.;
- Sanders, Charlene;
- Kolbe, Lloyd J.;
- Whyte, John J.;
- Wechsler, Howell;
- Schneider, Bruce S.;
- McNally, Laura A.;
- Charles-Azure, Jean;
- Vogel-Taylor, Martina;
- Starke-Reed, Pamela;
- Hubbard, Van S.;
- Johnson-Taylor, Wendy L.;
- Troiano, Richard P.;
- Donato, Karen;
- Yanovski, Susan;
- Kuczmarski, Robert J.;
- Haverkos, Lynne;
- McMurry, Kathryn;
- Wykoff, Randolph F.
Publication type:
Article
Risperidone-Associated Diabetes Mellitus: A Pharmacovigilance Study.
Published in:
Pharmacotherapy, 2003, v. 23, n. 6, p. 735, doi. 10.1592/phco.23.6.735.32178
By:
- Koller, Elizabeth A.;
- Cross, James T.;
- Doraiswamy, P. Murali;
- Schneider, Bruce S.
Publication type:
Article
Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome.
Published in:
1997
By:
- Kaiser, Nurit;
- Bailyes, Elaine M.;
- Schneider, Bruce S.;
- Cerasi, Erol;
- Steiner, Donald F.;
- Hutton, John C.;
- Gross, David J.;
- Kaiser, N;
- Bailyes, E M;
- Schneider, B S;
- Cerasi, E;
- Steiner, D F;
- Hutton, J C;
- Gross, D J
Publication type:
journal article
FDA Oversight of Cell Therapy Clinical Trials.
Published in:
Science Translational Medicine, 2012, v. 4, n. 149, p. 1, doi. 10.1126/scitranslmed.3004131
By:
- Au, Patrick;
- Hursh, Deborah A.;
- Lim, Agnes;
- Moos Jr., Malcolm C.;
- Oh, Steven S.;
- Schneider, Bruce S.;
- Witten, Celia M.
Publication type:
Article

Works matching AU Schneider, Bruce S.

Summary of the 2000 Surgeon General's Listening Session: Toward a National Action Plan on Overweight and Obesity.

Risperidone-Associated Diabetes Mellitus: A Pharmacovigilance Study.

Characterization of the unusual insulin of Psammomys obesus, a rodent with nutrition-induced NIDDM-like syndrome.

FDA Oversight of Cell Therapy Clinical Trials.